SYMBICORT 4.5 ug/1

SYMBICORT 4.5 ug/1 is a combination inhaler containing Budesonide and Formoterol Fumarate Dihydrate. It is used for managing respiratory conditions like asthma and COPD. This aerosol formulation is designed for inhalation and is manufactured by AstraZeneca Pharmaceuticals LP.

SYMBICORT 4.5 ug/1 is commonly used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). The Budesonide component is a corticosteroid that helps reduce inflammation in the lungs, while Formoterol is a long-acting bronchodilator that helps open the airways. This combination is often prescribed to improve breathing and reduce symptoms such as wheezing, shortness of breath, and coughing.

When used as directed, SYMBICORT 4.5 ug/1 may help improve lung function and reduce symptoms associated with respiratory conditions. Some users may experience common effects such as throat irritation, hoarseness, or a mild headache. It is important to follow the prescribed dosage and administration instructions to minimize potential side effects.

SYMBICORT 4.5 ug/1 should be used with caution in individuals with certain medical conditions, such as heart disease or diabetes. It is important to inform your healthcare provider about any existing health conditions or medications you are taking. Always use the inhaler as directed and store it properly to maintain its effectiveness.

SYMBICORT 4.5 ug/1 may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is advisable to consult with a healthcare provider before combining SYMBICORT with other treatments. Additionally, avoid using alcohol or other respiratory medications without medical advice.